Shilpa Pharma Lifesciences | Business Upturn

Latest Articles

Shilpa Pharma Lifesciences receives CEP for API, Nifedipine from EDQM

Corporates · Nov 19, 2024

blank

Shilpa Pharma Lifesciences Limited receives CEP from EDQM for Octreotide API

Corporates · Nov 18, 2024

This marks the second peptide molecule in Shilpa's expanding peptide portfolio.

By Matrika Shukla

blank

Shilpa Pharma Lifesciences gets certificate of suitability from EDQM for API, Desmopressin

Corporates · Oct 3, 2024